← The Wire
CLDXNasdaq
Celldex Therapeutics, Inc.
In Vitro & In Vivo Diagnostic Substances · DE · CIK 744218
Develops therapeutic antibodies targeting mast cell biology for severe inflammatory and allergic diseases
red 8-K · 90d
$2.45B
Market cap
$37.44
Last close
+6.2%
1D
+12.1%
5D
1.6M
Volume
Price · last 39 sessions+14.3%
May 4L $28.56 · H $37.44Jun 29
373
Total filings
Jun 26, 2026
Last filing
12/31
Fiscal year end
425425Jun 9, 2009425425May 29, 2009425425Feb 28, 2008425425Dec 14, 2007425425Nov 1, 2007425425Oct 31, 2007425425Oct 23, 2007425425Oct 23, 2007425425Oct 22, 2007425425Oct 22, 2007425425Oct 22, 2007425425Oct 22, 2007
Insider Activity
In the 90 days to Dec 4, 2025: 2 sold $1.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 4, 2025 | Jimenez Freddy A.SVP & GENERAL COUNSEL | Sell | 4,166 | $29.10 | $121K |
| Nov 13, 2025 | Wright Richard M.Other | Sell | 49,298 | $24.00 | $1.2M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance